Facilities

J&J completes €300m Irish expansion, adding 200 jobs

08-Oct-2019 By Ben Hargreaves

J&J announces the opening of its manufacturing building in Cork, Ireland, which expands the production capacity of the biopharmaceutical supply chain facility.

Top five stories from September

04-Oct-2019 By Ben Hargreaves

The news most interesting to our readers were those featuring collaborations, whether in the production of an Ebola vaccine, biosimilars entering new markets or creating new manufacturing modalities.

Astellas provides funding for US cell and gene therapy biotechs

03-Oct-2019 By Ben Hargreaves

Astellas to fund two biotech incubators, operated by LabCentral, to cultivate start-up companies focused on cell and gene therapies.

GSK invests $120m in genetics-focused US manufacturing hub

26-Sep-2019 By Ben Hargreaves

GSK’s biopharmaceutical manufacturing facility will be focused on the company’s pipeline of biologic medicines, including gene therapies, and vaccines.

CGT Catapult doubles capacity to accelerate manufacturing

25-Sep-2019 By Ben Hargreaves

CGT Catapult adds six additional clean room spaces to its Stevenage manufacturing center, to aid companies readying themselves for clinical and commercial manufacture.

Merck announces scale-up plans for Ebola vaccine production

18-Sep-2019 By Ben Hargreaves

Alongside receiving a priority review designation for its Ebola vaccine, Merck revealed that it planned to produce 650,000 additional doses.

Merz completes construction of new plant and filling line

17-Sep-2019 By Ben Hargreaves

Merz announces that it has completed the construction of a new plant for its botulinum neurotoxin product and unveils a ‘robot-controlled’ filling line.

GE Healthcare partners to create manufacturing suite for gene therapies

17-Sep-2019 By Ben Hargreaves

GE Healthcare teams up with Germfree to create a fully integrated, expandable manufacturing solution that is geared towards the development of ‘emerging biotherapeutics’.

Mallinckrodt agrees to sell CDMO business for $250m

11-Sep-2019 By Ben Hargreaves

Amid opioid lawsuits, Mallinckrodt looks to slim down its overall business by agreeing the sale of BioVectra to HIG.

Lonza works with Celltrion to ensure supply of Remsima drug substance

10-Sep-2019 By Ben Hargreaves

Lonza’s facility in Singapore will provide Celltrion with the drug substance product to meet demand for the latter’s Remsima biosimilar in the European and US market.

UPDATED

Trade secrets case sees biotech shutdown biosimilar production

09-Sep-2019 By Ben Hargreaves

Genentech reaches a settlement agreement with JHL Biotech, which sees the latter cease development of biosimilars to Genentech's products.

FDA warns of ‘unnecessary risk’ as AmEx pulls lots of Avastin over sterility concerns

03-Sep-2019 By Ben Hargreaves

The US FDA has followed up a public recall request to AmEx by hosting the manufacturer’s notice of a voluntary recall of Avastin, after sterility concerns.

Samsung BioLogics’ perfusion technology to ‘reduce production time by up to 30%’

03-Sep-2019 By Ben Hargreaves

Samsung BioLogics announces adoption of perfusion technology with alternating tangential flow for the commercial bioproduction process.

Massachusetts bioproduction employment outpaces national average

03-Sep-2019 By Ben Hargreaves

Biopharma employment levels in the state of have Massachusetts grown at a rate of 6% since 2009, bettering the national average of 1%.

UPDATED

Biocon insulin facility in Malaysia passes EU inspection

27-Aug-2019 By Vassia Barba

Asia’s largest integrated insulins facility, operated by a subsidiary of Biocon in Malaysia, receives GMP compliance certification from Ireland’s HPRA.